Hemato – Oncology Testing Market Worth $ 4.0 Billion by 2024 : Increasing Incidence Of Hematologic Cancer
Expected Revenue Growth: [116 Pages Report] The hemato oncology testing market is projected to reach USD 4.0 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 14.8% during the forecast period. Major Growth Drivers: Growth in this market is driven by the rising global prevalence of hematologic cancer, growing awareness regarding personalized medicines, and increasing collaborations for d..
카테고리 없음
2022. 1. 31. 19:00
